Paul Chew takes on new role at Sanofi-Aventis
This article was originally published in Scrip
Dr Paul Chew has been appointed chief science officer/chief medical officer US at Sanofi-Aventis US, effective from April 1st. He was previously president of R&D and Sanofi-Aventis US. Dr Chew will report to Greg Irace, president and CEO of Sanofi-Aventis US, in addition to Marc Cluzel, group senior vice-president of R&D and Jean-Pierre Lehner, group chief medical officer.